| Gender aspects of CGRP in migraine A Labastida-Ramírez, E Rubio-Beltrán, CM Villalón, ... Cephalalgia 39 (3), 435-444, 2019 | 111 | 2019 |
| Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy? E Rubio-Beltrán, A Labastida-Ramírez, CM Villalón, ... Pharmacology & therapeutics 186, 88-97, 2018 | 102 | 2018 |
| Long COVID headache C Tana, E Bentivegna, SJ Cho, AM Harriott, D García-Azorín, ... The journal of headache and pain 23 (1), 93, 2022 | 88 | 2022 |
| Current understanding of meningeal and cerebral vascular function underlying migraine headache D Levy, A Labastida-Ramirez, A MaassenVanDenBrink Cephalalgia 39 (13), 1606-1622, 2019 | 84 | 2019 |
| Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system A Labastida-Ramírez, E Rubio-Beltrán, KA Haanes, KY Chan, IM Garrelds, ... Pain 161 (5), 1092-1099, 2020 | 77 | 2020 |
| Characterization of binding, functional activity, and contractile responses of the selective 5‐HT1F receptor agonist lasmiditan E Rubio‐Beltrán, A Labastida‐Ramírez, KA Haanes, A van den Bogaerdt, ... British Journal of Pharmacology 176 (24), 4681-4695, 2019 | 68 | 2019 |
| Migraine and cluster headache–the common link AL Vollesen, S Benemei, F Cortese, A Labastida-Ramírez, F Marchese, ... The journal of headache and pain 19, 1-15, 2018 | 66 | 2018 |
| Triptans and CGRP blockade–impact on the cranial vasculature S Benemei, F Cortese, A Labastida-Ramírez, F Marchese, L Pellesi, ... The journal of headache and pain 18, 1-7, 2017 | 63 | 2017 |
| Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence A Labastida-Ramírez, S Benemei, M Albanese, A D’Amico, G Grillo, ... The journal of headache and pain 21, 1-15, 2020 | 48 | 2020 |
| Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteries E Rubio-Beltrán, A Labastida-Ramírez, KA Haanes, A van den Bogaerdt, ... Cephalalgia 39 (14), 1735-1744, 2019 | 31 | 2019 |
| Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models KA Haanes, A Labastida-Ramírez, FW Blixt, E Rubio-Beltrán, CM Dirven, ... Cephalalgia 39 (11), 1421-1434, 2019 | 28 | 2019 |
| Characterization of the trigeminovascular actions of several adenosine A2A receptor antagonists in an in vivo rat model of migraine KA Haanes, A Labastida-Ramírez, KY Chan, R de Vries, B Shook, ... The journal of headache and pain 19, 1-10, 2018 | 22 | 2018 |
| Trigeminovascular calcitonin gene-related peptide function in Cacna1a R192Q-mutated knock-in mice KY Chan, A Labastida-Ramírez, MB Ramírez-Rosas, S Labruijere, ... Journal of Cerebral Blood Flow & Metabolism 39 (4), 718-729, 2019 | 18 | 2019 |
| Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence S Benemei, A Labastida-Ramírez, E Abramova, N Brunelli, E Caronna, ... The journal of headache and pain 21, 1-10, 2020 | 16 | 2020 |
| Lasmiditan inhibits CGRP release in the mouse trigeminovascular system. A Labastida-Ramirez, E Rubio-Beltran, IM Garrelds, KA Haanes, KY Chan, ... Cephalalgia 37, 362-363, 2017 | 14 | 2017 |
| Mode and site of action of therapies targeting CGRP signaling A Labastida-Ramírez, E Caronna, C Gollion, E Stanyer, A Dapkute, ... The journal of headache and pain 24 (1), 125, 2023 | 8 | 2023 |
| Pharmacological analysis of the increases in heart rate and diastolic blood pressure produced by (S)-isometheptene and (R)-isometheptene in pithed rats A Labastida-Ramírez, E Rubio-Beltrán, O Hernández-Abreu, ... The Journal of Headache and Pain 18, 1-8, 2017 | 6 | 2017 |
| Potential antimigraine effects of warfarin: An exploration of biological mechanism with survey of patients B Nilsson, V Back, R Wei, F Plane, P Jurasz, TJ Bungard TH Open 3 (02), e180-e189, 2019 | 5 | 2019 |
| Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America M Lisicki, MNP Souza, AB de Oliveira, E Rubio-Beltran, ... Cephalalgia 42 (10), 1086-1090, 2022 | 4 | 2022 |
| In vitro characterization of agonist binding and functional activity at a panel of serotonin receptor subtypes for lasmiditan, triptans and other 5-HT receptor ligands and … E Rubio-Beltran, A Labastida-Ramirez, A Van den Bogaerdt, AJ Bogers, ... Cephalalgia 37, 363-363, 2017 | 4 | 2017 |
Eloísa Rubio-BeltránKing's College London. Institute of Psychiatry, Psychology and NeurosciencesAdresse e-mail validée de kcl.ac.uk
